1. nomaam4565
2. pierceton
3. dianamoonblade1
4. SugarDaddy
5. nshsn8vjkdpyvqf
1.SugarDaddy 02/21/2018
Announces positive top-line results from Phase 3 study
2.dianamoonblade1 02/05/2018
Granted orphan drug designation by the FDA for Imbruvica for the treatment of gastric cancer, including gast…
3.SugarDaddy 10/18/2017
{Image}
4.dianamoonblade1 03/27/2018
Chicago jury has ordered AbbVie to pay a man $3M who claimed the company misrepresented the risks of its tes…
5.pierceton 01/26/2018
AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results
6.pierceton 01/26/2018
ABBV leads the way today as the best performing large cap stock, closing up 13.77%.
7.dianamoonblade1 02/18/2018
AbbVie Announces New Phase 2 Data for Upadacitinib Showing Clinical and Endoscopic Outcomes in Crohn's Disease at 52 Weeks
8.nomaam4565 03/22/2018
The company's massive Rova-T program has delivered disappointing results.
9.nomaam4565 07/27/2018
Sees FY18 EPS $7.76-7.86 (Prior $7.66-7.76)
10.SugarDaddy 07/24/2018
Receives FDA approval of ORILISSA (elagolix) for the management of moderate to severe pain
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW